Insider trade

Director sold ~$92K of CME shares in the open market

Traded Feb 20, 2026 · Filed Feb 20, 2026

CME GroupCME

~$92K
Reported value · 300 sh @ $305.90: 25K
Holds after · shares reported: -12.3%
stock since the trade · S&P 500 +12.4%, $308.09 → $270.03 on Oct 5

Why it stands out

A board member of CME Group sold $92K of CME Group shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 20, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 20, 2026

Director$25K–$100K

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$91,770

Shares × reported transaction price

Timing vs results

16 days after results of Feb 4, 2026, 61 days before results of Apr 22, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $308.09 on Feb 20, 2026, at its 52-week high, after a 15% rise over the previous 30 trading days

52-week range $247.75 (Feb 24, 2025) to $308.09 (Feb 20, 2026), 100% of the way up, from 251 adjusted closes. 30 trading days earlier: $266.845 on Jan 7, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on Jun 14, 2024 in the U.S. District Court, S.D. New York. A filing is an allegation, not a finding.

Global Carbon Opportunity (Cayman) Fund Ltd. v. CME Group Inc., docket 1:24-cv-04562, via CourtListener (court records). Nature of suit 850, company named as first defendant